Spain's Grifols reports fivefold increase in 2012 profit
MADRID Feb 28 (Reuters) - Spanish pharmaceutical company Grifols reported a more than fivefold rise in full-year profit for 2012 to 257 million euros ($336.90 million), buoyed by its acquisition of U.S. firm Talecris last June and its wide geographic presence outside its depressed home market.
Barcelona-based Grifols said sales grew 46 percent year-on-year to reach 2.6 billion euros, in line with analyst expectations. ($1 = 0.7628 euros) (Reporting By Sonya Dowsett; Editing by Clare Kane)
- Radar showed missing plane may have turned back: Malaysia military
- Malaysian jetliner may have turned back before vanishing |
- Malaysian plane presumed crashed; questions over false IDs |
- Russian forces tighten grip on Crimea despite U.S. warning |